As Covid-19 continues to sweep the globe, health systems around the world are facing unprecedented pressure as they are overwhelmed by people requiring immediate care due to the virus. In recent weeks, Australia has implemented a number of public measures in a bid to curb the spread of Covid-19 and ensure our health system is able to cope, not only for those affected by the virus, but for every other Australian who still requires life-saving care throughout this period.
This is the case for the tens of thousands of Australians living with cancer who still need ongoing treatment, many of whom don’t have the luxury of time. The unfortunate reality is, global pandemic or otherwise, cancer doesn’t stop.
• Cancer is a major cause of illness in Australia, with 150,000 new cases of cancer estimated to be diagnosed in Australia this year alone
• It is estimated that one in two Australians will be diagnosed with cancer by the age of 85
• Cancer is a leading cause of death in Australia, accounting for nearly one in three deaths nationally
• In 2019, breast cancer was the most commonly diagnosed cancer in Australia, accounting for 14 per cent of new cancer cases, followed by prostate cancer
• Immediate access to radiation therapy for those with breast cancer is critical, with recent data confirming delays to treatment lead to worse patient outcomes.
With the reallocation of healthcare resources in Australia to Covid-19 detection and treatment, Australians living with cancer, and those who will be newly diagnosed during this period, may face the additional stress of potential restrictions or delays in accessing treatment.
While more than 80 per cent of confirmed Covid-19 cases are considered to be mild, people with cancer, especially those immunocompromised by certain cancer treatments, are at higher risk of developing more severe symptoms if they contract the virus. In particular, individuals with lung cancer may be at increased risk of developing a more severe respiratory infection from the virus.
Cancer treatments such as chemotherapy can suppress and weaken the immune system, reducing its ability to fight off bacterial and viral infections. Radiation therapy, while it doesn’t increase the chances of contracting Covid-19, does decrease one type of white blood cells (lymphocytes), which can also reduce the body’s ability to fight infection.
However, it’s important to remember that during this time, clinicians and oncology teams are working harder than ever to adapt to the current conditions and Covid-19-related restrictions to ensure vital cancer treatment continues to be made available to those who need it.